Food and Drug Administration
September 8, 2005
Briefing Information
PMA P040033 - Birmingham Hip Resurfacing (BHR) System (PDF)
Panel Recommendation Options For Premarket Approval Applications (HTM) (PDF) (Word)
Summary of Safety and Effectiveness Data (PDF)
Draft Packaging Insert (PDF)
Draft Patient Labeling (PDF)